Bendamustine in combination with rituximab (BR) for patients with relapsed chronic lymphocytic leukemia (CLL): A multicentre phase II trail of the German CLL Study Group (GCLLSG).

被引：6
|
作者：
Fischer, Kirsien [1 ]
Stilgenbauer, Stephan [2 ]
Schweighofer, Carmen D. [1 ]
Renschler, Jasmin [1 ]
Busch, Raymonde [3 ]
Kiehl, Michael [4 ]
Balleisen, Leopold [5 ]
Eckart, Michael [6 ]
Fink, Anna M. [1 ]
Boettcher, Sebastian [7 ]
Ritgen, Matthias [7 ]
Kneba, Michael [7 ]
Staib, Peter [1 ]
Doehner, Hartmut [2 ]
Eichhorst, Barbara F. [1 ]
Hallek, Michael [1 ]
机构：
[1] Univ Hosp, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp, Dept Internal Med, Ulm, Germany
[3] Tech Univ, Inst Med Stat & Epidemiol, Munich, Germany
[4] Hospital, Dept Internal Med, Frankfurt, Germany
[5] Hospital, Dept Internal Med, Hamm, Germany
[6] ISP Naegelsbacherstr, Erlangen, Germany
[7] Univ Hosp, Dept Internal Med, Kiel, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3106.3106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3106
引用
收藏
页码：913A / 914A
页数：2
相关论文
共 50 条
  • [1] Bendamustine in Combination with Rituximab (BR) for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase II Trial of the German CLL Study Group (GCLLSG)
    Fischer, Kirsten
    Stilgenbauer, Stephan
    Schweighofer, Carmen D.
    Busch, Raymonde
    Renschler, Jasmin
    Kiehl, Michael
    Balleisen, Leopold
    Eckart, Michael J.
    Fink, Anna-Maria
    Kilp, Julia
    Ritgen, Matthias
    Boettcher, Sebastian
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Wendtner, Clemens-Martin
    BLOOD, 2008, 112 (11) : 128 - 128
  • [2] Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG)
    Koeppler, Hubert
    Fuss, Harald
    Hurtz, Hans J.
    Knigge, Owe
    Losem, Christoph
    Reschke, Daniel
    Schmitz, Stephan
    Weide, Rudolf
    Weiss, Johann
    Hallek, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (02) : 238 - 241
  • [3] BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY
    Iannitto, E.
    Morabito, F.
    Mancuso, S.
    Gentile, M.
    Augello, A.
    Bongarzoni, V.
    Cascavilla, N.
    D'Arco, A.
    Di Renzo, N.
    Fazzi, R.
    Ferrara, F.
    Franco, G.
    Gobbi, M.
    Liardo, E.
    Liberati, A. M.
    Marasca, R.
    Montanini, A.
    Mule, A.
    Musso, M.
    Musto, P.
    Pennese, E.
    Piccin, A.
    Scalabrini, D. Rota
    Sciacca, M.
    Visani, G.
    Abbadessa, V.
    Rigacci, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 323 - 323
  • [4] Bendamustine Followed By Ofatumumab and Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BIO Trial of the German CLL Study Group (GCLLSG)
    Cramer, Paula
    von Tresckow, Julia
    Robrecht, Sandra
    Bahlo, Jasmin
    Al-Sawaf, Othman
    Langerbeins, Petra
    Heinz, Werner
    Vehling-Kaiser, Ursula
    Durig, Jan
    Tausch, Eugen
    Hensel, Manfred
    Fink, Anna-Maria
    Fischer, Kirsten
    Kreuzer, Karl-Anton
    Bottcher, Sebastian
    Ritgen, Matthias
    Kneba, Michael
    Wendtner, Clemens-Martin
    Stilgenbauer, Stephan
    Eichhorst, Barbara F.
    Hallek, Michael J.
    BLOOD, 2017, 130
  • [5] Bendamustine Followed By Obinutuzumab and Idelalisib in Patients with Chronic Lymphocytic Leukemia (CLL): CLL2-BCG Trial of the German CLL Study Group (GCLLSG)
    Cramer, Paula
    Von Tresckow, Julia
    Fink, Anna-Maria
    Braun, Gracia
    Robrecht, Sandra
    Zhang, Can
    Tausch, Eugen
    Mueller, Lothar
    Knauf, Wolfgang
    Al-Sawaf, Othman
    Pelzer, Benedikt
    Langerbeins, Petra
    Fischer, Kirsten
    Kreuzer, Karl-Anton
    Ritgen, Matthias
    Kneba, Michael
    Wendtner, Clemens-Martin
    Stilgenbauer, Stephan
    Eichhorst, Barbara
    Hallek, Michael
    BLOOD, 2020, 136
  • [6] Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
    Bergmann, Manuela A.
    Goebeler, Maria E.
    Herold, Michael
    Emmerich, Bertold
    Wilhelm, Martin
    Ruelfs, Corinna
    Boening, Lothar
    Hallek, Michael J.
    HAEMATOLOGICA, 2005, 90 (10) : 1357 - 1364
  • [7] Bendamustine Combined with Rituximab (BR) in First-Line Therapy of Advanced CLL: A Multicenter Phase II Trial of the German CLL Study Group (GCLLSG)
    Fischer, Kirsten
    Cramer, Paula
    Stilgenbauer, Stephan
    Busch, Raymonde
    Balleisen, Leopold
    Kilp, Julia
    Fink, Anna-Maria
    Boettcher, Sebastian
    Ritgen, Matthias
    Kneba, Michael
    Staib, Peter
    Doehner, Hartmut
    Schulte, Silke
    Eichhorst, Barbara F.
    Hallek, Michael
    Wendtner, Clemens-Martin
    BLOOD, 2009, 114 (22) : 89 - 89
  • [8] Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study
    Gentile, Massimo
    Ciolli, Stefania
    Molica, Stefano
    Di Renzo, Nicola
    Selleri, Carmine
    Villa, Maria Rosaria
    De Paolis, Maria Rosaria
    Scortechini, Ilaria
    Giannotta, Angela
    Minoia, Carla
    Rago, Angela
    Boncompagni, Riccardo
    Bonanno, Vincenza
    Levato, Luciano
    Musso, Maurizio
    Mastrullo, Lucia
    Melpignano, Angela
    Murru, Roberta
    Angelucci, Emanuele
    Tarantini, Giuseppe
    Caparrotti, Giuseppe
    Guarini, Attilio
    Ferrara, Felicetto
    Cimino, Giuseppe
    Zinzani, Pier Luigi
    Morabito, Fortunato
    BLOOD, 2014, 124 (21)
  • [9] Impact of Gender on Outcome after Chemoimmunotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) or Bendamustine Plus Rituximab (BR) in Patients with Chronic Lymphocytic Leukemia (CLL): A Meta-Analysis of Three Phase II/III Studies of the German CLL Study Group (GCLLSG)
    Al-Sawaf, Othman
    Robrecht, Sandra
    Bahlo, Jasmin
    Fink, Anna Maria
    Cramer, Paula
    Maurer, Christian
    Bergmann, Manuela A.
    Dreyling, Martin H.
    Lange, Elisabeth
    Kneba, Michael
    Stilgenbauer, Stephan
    Dohner, Hartmut
    Kiehl, Michael G.
    Jager, Ulrich
    Wendtner, Clemens-Martin
    Fischer, Kirsten
    Hallek, Michael
    Eichhorst, Barbara F.
    Hopfinger, Georg
    BLOOD, 2016, 128 (22)
  • [10] Bendamustine (B), followed by obinutuzumab (G) and venetoclax (A) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG trial of the German CLL Study Group (GCLLSG)
    Cramer, P.
    von Tresckow, J.
    Bahlo, J.
    Robrecht, S.
    Al-Sawaf, O.
    Langerbeins, P.
    Engelke, A.
    Fink, A. -M.
    Fischer, K.
    Tausch, E.
    Seiler, T.
    von Weikersthal, Fischer L.
    Hebart, H.
    Kreuzer, K. -A.
    Ritgen, M.
    Kneba, M.
    Wendtner, C. -M.
    Stilgenbauer, S.
    Eichhorst, B.
    Hallek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 24 - 24
12345